YOLFTbeta
Shanghai RAAS Blood Products Co Ltd Class A

Shanghai RAAS Blood Products Co Ltd Class A

002252 · SHE · Healthcare / Biotechnology

4.66CNY-0.10 (-2.10%)

Price History

Full chart

Market Stats

Previous Close4.76
Open4.74
Day Range4.65 – 4.75
52-Week Range4.18 – 6.90
Volume44.57M
Market Cap35.07B
P/E (TTM)28.00
Forward P/E112.36
EPS0.19
Dividend Yield1.53%
Beta0.28
50-Day Avg5.00
200-Day Avg5.54

About

Shanghai RAAS Blood Products Co., Ltd., together with its subsidiaries, produces and sells blood products in China and internationally. The company offers ALBURAAS, which is albumin prepared from human plasma; GAMARAAS, a human immunoglobulin product for intravenous injections; HEMORAAS, a human coagulation factor VIII product; PROTHORAAS, a human prothrombin complex; FIBRORAAS, a human fibrinogen; FIBINGLURAAS, a fibrin sealant for humans; and THROMBIRAAS, a human thrombin product. It also provides specific immune, human tetanus immunoglobulin, human rabies immunoglobulin, human immunoglobulin, hepatitis B human immunoglobulin, and other blood products. The company exports its products. Shanghai RAAS Blood Products Co., Ltd. was founded in 1988 and is headquartered in Shanghai, China.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Jun Xu
  • Employees4.04K
  • HeadquartersNo. 2009, Wangyuan Road, Shanghai, China, 201401, China
  • Websitehttps://www.raas-corp.com

Leadership

  • Mr. Jun XuGM & Vice Chairman · b. 1964
  • Mr. Leqi ChenHead of Finance · b. 1987
  • Mr. Zheng LiuDeputy GM & Secretary of Board of Directors · b. 1970
  • Mr. Ji Hui ShenDeputy General Manager · b. 1966
  • Mr. Hui LuDeputy General Manager · b. 1975
  • Ms. Zhengmin SongDeputy General Manager · b. 1968
  • Mr. Qin Bing HuangDeputy General Manager · b. 1977
  • Ms. Xi ZhaoHead of Accounting
  • Mr. Yang Gu M.D.Director of Sales & Marketing

Financials

Income Statement

Currency: CNY2005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue303.19M278.69M309.98M309.86M387.52M483.36M567.39M662.68M496.36M1.32B2.01B2.33B1.93B1.80B2.58B2.76B4.29B6.57B7.96B8.18B7.35B
Growth (%)--8.08%+11.23%-0.04%+25.06%+24.73%+17.38%+16.79%-25.10%+165.88%+52.55%+15.54%-17.13%-6.41%+43.27%+6.84%+55.26%+53.16%+21.27%+2.67%-10.13%
Cost of Revenue187.67M174.28M140.02M116.45M164.67M179.51M232.77M265.28M175.29M494.32M777.13M844.46M705.53M617.37M935.99M1.06B2.07B3.68B4.73B4.87B4.60B
Gross Profit115.53M104.41M169.95M193.41M222.85M303.84M326.59M397.39M321.07M825.41M1.24B1.48B1.22B1.19B1.65B1.70B2.22B2.89B3.23B3.30B2.75B
Gross Margin38.10%37.47%54.83%62.42%57.51%62.86%57.56%59.97%64.69%62.54%61.40%63.70%63.40%65.78%63.79%61.64%51.75%43.99%40.55%40.41%37.37%
Operating Expense53.80M44.85M57.10M66.57M74.59M93.33M98.74M141.52M153.68M226.00M-493.13M-466.34M214.74M2.94B913.05M200.40M664.25M610.11M1.00B622.41M831.97M
Operating Income61.73M59.56M112.85M126.84M148.26M210.51M227.86M255.88M167.39M599.41M1.73B1.95B1.01B-1.75B735.94M1.50B1.55B2.28B2.23B2.68B1.91B
Operating Margin20.36%21.37%36.41%40.94%38.26%43.55%40.16%38.61%33.72%45.42%85.89%83.75%52.26%-97.08%28.47%54.38%36.26%34.70%27.94%32.80%26.05%
EBITDA74.46M74.96M118.77M141.21M177.79M234.31M250.51M270.77M199.27M641.20M944.16M1.21B907.24M584.22M1.04B1.17B1.62B2.17B2.48B2.29B1.82B
EBITDA Margin24.56%26.90%38.31%45.57%45.88%48.48%44.15%40.86%40.15%48.59%46.90%52.20%47.06%32.38%40.41%42.45%37.69%33.03%31.10%28.04%24.83%
Net Income51.24M50.71M81.77M104.79M135.66M185.50M200.35M225.01M143.79M510.85M1.44B1.61B835.83M-1.52B607.89M1.32B1.29B1.88B1.78B2.19B1.58B
Net Income Margin16.90%18.20%26.38%33.82%35.01%38.38%35.31%33.96%28.97%38.71%71.64%69.35%43.36%-84.16%23.52%47.93%30.19%28.63%22.34%26.82%21.46%
R&D-------24.39M22.41M46.58M101.01M76.71M96.93M96.18M102.44M129.69M129.02M145.71M173.74M250.90M223.37M
R&D as % of Total Revenue-------3.68%4.52%3.53%5.02%3.30%5.03%5.33%3.96%4.70%3.01%2.22%2.18%3.07%3.04%
Interest Expense4.19M3.77M4.03M2.51M1.54M67.20K56.68K42.82K16.19M23.63M22.27M35.09M70.91M66.03M2.20M658.93K1.24M263.18K457.88K958.62K44.60M
Interest Expense % of Total Revenue1.38%1.35%1.30%0.81%0.40%0.01%0.01%0.01%3.26%1.79%1.11%1.51%3.68%3.66%0.09%0.02%0.03%0.00%0.01%0.01%0.61%

Balance Sheet

Currency: CNY2005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets333.63M325.16M306.54M831.19M825.22M930.33M1.01B1.21B1.58B9.38B11.56B13.23B14.46B11.40B11.85B25.49B27.24B30.46B31.93B33.63B37.80B
Total Liabilities101.93M168.39M136.53M76.42M61.88M99.12M82.26M188.79M473.37M755.16M843.64M1.50B1.98B496.56M361.95M363.74M1.33B1.64B2.28B1.69B5.34B
Total Equity231.45M156.47M168.05M751.23M758.57M824.07M914.64M1.00B1.09B8.61B10.66B11.71B12.46B10.89B11.48B25.12B25.90B28.82B29.63B31.93B32.46B
Cash22.56M23.63M56.39M557.88M463.40M457.83M363.12M362.10M329.54M1.45B1.92B2.09B1.39B865.55M1.44B1.95B2.75B3.98B4.00B2.98B1.34B
Total Debt58.00M57.00M38.00M29.01M----356.53M358.02M359.60M384.00M360.00M150.00M-7.74M4.16M1.85M1.49M12.99M3.95B
Net Debt35.44M33.37M-18.39M-528.87M-463.40M-457.83M-363.12M-362.10M26.99M-1.09B-1.56B-1.70B-1.39B-715.55M-1.44B-1.94B-2.74B-3.98B-4.00B-2.97B2.61B

Cash Flow

Currency: CNY2005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow54.02M53.58M175.71M107.64M116.01M200.21M178.03M263.46M-90.11M465.96M762.42M638.22M268.76M262.50M872.69M1.17B1.29B1.73B2.28B-482.06M-104.89M
Investing Cash Flow-21.69M-17.68M-29.14M-28.65M-50.99M-93.57M-171.34M-135.03M-272.68M289.88M-818.74M-765.65M-1.44B677.84M-152.33M-608.73M-730.82M-1.13B-670.59M-915.92M-2.53B
Financing Cash Flow-22.51M-34.93M-113.85M422.88M-159.43M-117.53M-95.91M-129.27M331.60M365.17M523.92M292.62M473.78M-1.46B-150.44M-58.84M-179.28M-193.38M-1.13B-464.41M2.62B
Capital Expenditure21.69M12.08M24.46M29.23M60.99M89.21M176.80M149.70M129.68M65.06M145.39M147.49M157.84M156.94M154.84M251.76M204.61M225.73M450.80M407.15M379.02M
Free Cash Flow32.32M41.50M151.25M78.41M55.02M111.00M1.23M113.77M-219.79M400.90M617.03M490.74M107.11M105.56M717.86M917.09M1.09B1.50B1.83B-889.20M-483.91M
Dividends Paid5.59M37.10M93.32M52.55M129.53M120.00M108.80M136.00M24.48M80.52M156.78M172.43M218.45M166.59M1.60M67.78M168.55M188.74M202.22M439.85M317.88M
FCF to OCF59.84%77.45%86.08%72.85%47.42%55.44%0.69%43.18%243.92%86.04%80.93%76.89%39.85%40.21%82.26%78.46%84.19%86.92%80.21%184.46%461.34%
Dividend Paid to FCF17.30%89.40%61.70%67.02%235.44%108.11%8829.33%119.54%-11.14%20.08%25.41%35.14%203.95%157.81%0.22%7.39%15.47%12.58%11.07%-49.47%-65.69%

Earnings

Report DateAug 24, 2009Jun 2, 2010Sep 1, 2010Dec 1, 2010Mar 2, 2011Jun 1, 2011Aug 31, 2011Nov 30, 2011Feb 29, 2012May 30, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013Apr 19, 2013Aug 10, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Jul 30, 2014Oct 29, 2014Feb 13, 2015Apr 15, 2015Aug 17, 2015Oct 30, 2015Feb 27, 2016Apr 27, 2016Aug 31, 2016Oct 23, 2016Feb 25, 2017Apr 28, 2017Jul 30, 2017Oct 24, 2017Apr 30, 2018Jul 27, 2018Oct 28, 2018Apr 25, 2019Aug 8, 2019Oct 24, 2019Apr 25, 2020Aug 27, 2020Oct 29, 2020Apr 23, 2021Aug 27, 2021Oct 29, 2021Apr 22, 2022Aug 30, 2022Oct 29, 2022Apr 27, 2023Aug 29, 2023Oct 24, 2023Dec 31, 2023Apr 29, 2024Aug 27, 2024Oct 28, 2024Dec 31, 2024Apr 17, 2025Aug 29, 2025Oct 28, 2025Mar 26, 2026Apr 30, 2026Aug 25, 2026
EPS Estimate0.01------------0.010.02-0.01------0.04-0.03---0.06--------------------0.050.120.090.100.040.040.090.080.04--
EPS Actual0.010.010.010.020.020.010.020.020.020.010.010.020.020.010.020.02-0.000.020.030.030.040.080.090.060.060.050.070.120.080.030.100.05-0.14-0.03-0.090.040.040.040.000.060.060.030.070.07-0.020.080.080.040.080.080.000.110.080.090.050.050.070.060.020.050.05
Surprise0.00%------------0.00%0.00%--113.00%------50.00%-66.67%----50.00%---------------------92.00%-8.33%-11.11%-10.00%25.00%25.00%-22.22%-25.00%-50.00%--
TimingAfter-hours------------After-hoursAfter-hours-After-hours-Pre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-market--------Pre-market--Pre-marketAfter-hoursPre-market-After-hoursAfter-hoursPre-market-After-hoursAfter-hours-After-hours--

Key Statistics & Ratios

Market Cap35.07B
Enterprise Value34.75B
Trailing P/E28.00
Forward P/E112.36
PEG Ratio0.00
Price / Sales5.31
Price / Book1.01
EPS0.19
Book Value4.88
Revenue (TTM)6.61B
Gross Profit (TTM)2.34B
EBITDA1.42B
Profit Margin18.29%
Operating Margin14.50%
Return on Equity3.73%
Return on Assets1.94%
Shares Outstanding6.59B
Shares Float4.48B
Beta0.28
Dividend Yield1.53%
Dividend Rate0.08
Payout Ratio26.79%

Dividends

20262×
0.03Jun 24, 20260.02Feb 10, 2026
20251×
0.03Jul 14, 2025
20242×
0.04Sep 30, 20240.03Jun 5, 2024
20231×
0.03Jun 13, 2023
20221×
0.03Jul 7, 2022
20211×
0.03Jul 2, 2021
20201×
0.01Jul 15, 2020
20181×
0.02Jun 28, 2018
20171×
0.03Jun 20, 2017
20161×
0.03May 27, 2016
20151×
0.03Apr 9, 2015
20141×
0.01Apr 24, 2014
20131×
0.01May 16, 2013
20121×
0.04May 8, 2012
20111×
0.03May 24, 2011
20101×
0.03May 18, 2010
20091×
0.04May 7, 2009

Stock Splits

  • Sep 28, 201618:10
  • Sep 17, 201520:10
  • Sep 25, 201420:10
  • May 8, 201218:10
  • Oct 19, 201017:10